Te Ahumairangi Investment Management Ltd acquired a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 50,511 shares of the company’s stock, valued at approximately $6,491,000. Merck KGaA makes up approximately 1.0% of Te Ahumairangi Investment Management Ltd’s portfolio, making the stock its 29th largest position.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Frazier Financial Advisors LLC bought a new position in Merck KGaA in the 2nd quarter valued at $25,000. Rakuten Securities Inc. bought a new stake in Merck KGaA during the second quarter valued at $27,000. Burk Holdings LLC bought a new stake in Merck KGaA during the second quarter valued at $39,000. Bard Associates Inc. bought a new position in Merck KGaA in the 2nd quarter worth about $60,000. Finally, Kilter Group LLC purchased a new stake in shares of Merck KGaA in the 2nd quarter valued at about $62,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
MKGAF stock opened at $163.21 on Monday. The company’s 50 day moving average is $162.62 and its 200 day moving average is $148.44. The stock has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
